Challenge: A leading specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory […]
March 1, 2018Three ARG team members attended 2018 Rare Disease Week on Capitol Hill: Senior Data Manager Darlene Adams, Project Manager Catherine […]
February 28, 2018Each quarter, ARG CEO Paul Bishop and President Lyle Camblos will share their thoughts and responses concerning relevant company and […]
February 20, 2018Challenge: A specialty biopharmaceutical company targeting the therapeutic power of plasma for the treatment of chronic, life-altering diseases like hemophilia […]
February 1, 2018One of the main reasons why ARG has consistently produced excellent clinical trial work over the years has been because […]
January 28, 2018By using a smarter automated approach to validation, we are able to cut down build timelines as well as identify and correct more errors prior to go-live.
January 18, 2018